Loading
Posaconazole is an antifungal medicine. Its label includes preventing mould and yeast infections in people with blood cancers whose white cells stay low for a long time after chemotherapy.
The Noxafil label covers treatment of invasive aspergillosis, and "prophylaxis of invasive Aspergillus and Candida infections in patients who are at high risk of developing these infections due to being severely immunocompromised, such as hematopoietic stem cell transplant (HSCT) recipients with graft-versus-host disease (GVHD) or those with hematologic malignancies with prolonged neutropenia from chemotherapy", as well as oropharyngeal candidiasis. The ECIL-10 guideline (2025) considers isavuconazole for adults in remission induction for acute myeloid leukaemia "for whom posaconazole is not appropriate", and notes literature support for posaconazole during the first four cycles of azacitidine in high-risk MDS. ECIL notes that the drug interaction between triazoles and vincristine, part of most acute lymphoblastic leukaemia regimens, hampers antifungal prophylaxis there. The NDA was first approved on 15 September 2006.
A triazole antifungal that blocks ergosterol synthesis in the fungal cell membrane.
1.Posaconazole slips into a pocket on its target.
| Region | Year | Indication |
|---|---|---|
| US | 2006 | Prophylaxis of invasive Aspergillus and Candida infections in severely immunocompromised patients (HSCT with GVHD, haematological malignancies with prolonged neutropenia from chemotherapy); invasive aspergillosis; oropharyngeal candidiasis · Year is the Noxafil NDA 022003 approval (Drugs@FDA) |
Country and place are remembered in this browser only. A postcode is sent to OpenStreetMap's Nominatim service to find coordinates when you press the button; nothing else leaves your device.
Query for this drug: (TITLE:"Posaconazole" OR ABSTRACT:"Posaconazole" OR TITLE:"Noxafil" OR ABSTRACT:"Noxafil") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Posaconazole, not a curated reading list.
Shares Neutropenia and the tags supportive, generic, supportive-care-gaps-2026-11.
Shares Neutropenia and the tags supportive, generic, supportive-care-gaps-2026-11.
Shares the tags supportive, generic, supportive-care-gaps-2026-11.
Shares the tags supportive, generic, supportive-care-gaps-2026-11.
Shares the tags supportive, generic, supportive-care-gaps-2026-11.
Shares the tags supportive, generic, supportive-care-gaps-2026-11.
Shares the tags supportive, generic, supportive-care-gaps-2026-11.
Shares the tags supportive, generic, supportive-care-gaps-2026-11.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/